Morgan J. Whitmore, MD

Purpose: To describe the use of Y-90 radioembolization (Y-90 RE) for unresectable high risk hepatic adenoma in a patient with chronic liver disease.

11/15/2021

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11